News

Key News - Bajaj Healthcare, Oppo India, LIC, IndusInd Bank, NTPC, Nissan By ARETE Securities Key News Bajaj Healthcare forays into highly-regulated opiate processing business Bajaj Healthcare on Wednesday said it has forayed into the highly regulated opiate processing business. The company said it has received two orders from the central government to produce active pharmaceutical ingredients (API) from poppy capsules and other derivatives on an annual basis. It plans to execute both these tenders from its API manufacturing unit located at Savli, Gujarat.   Chinese ...
Key News - Bajaj Healthcare, Oppo India, LIC, IndusInd Bank, NTPC, Nissan By ARETE Securities
Key News - Bajaj Healthcare, Oppo India, LIC, IndusInd Bank, NTPC, Nissan By ARETE Securities
Source: ARETE Securities Ltd
14/07/2022 9:37:13 AM
Bajaj Healthcare shines on foraying into highly regulated- Opiate Processing Business for GOI Bajaj Healthcare is currently trading at Rs. 358.00, up by 17.05 points or 5.00% from its previous closing of Rs. 340.95 on the BSE. The scrip opened at Rs. 345.00 and has touched a high and low of Rs. 365.00 and Rs. 345.00 respectively. So far 5015 shares were traded on the counter. The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 499.00 on 13-Jul-2021 and a 52 week low of Rs. 256.80 on 20-Jun-2022. Last one week high and low of the scrip stood a...
Bajaj Healthcare shines on foraying into highly regulated- Opiate Processing Business for GOI
Bajaj Healthcare shines on foraying into highly regulated- Opiate Processing Business for GOI
Source: Accord Fintech
13/07/2022 9:44:14 AM
Bajaj Healthcare Q4 net profit down 17.90% at Rs 17.47 cr The company reported standalone net profit of Rs 17.47 crore for the quarter ended March 31, 2022 as compared to Rs 21.28 crore in the same period last year, registering a year-on-year decline of 17.90 per cent. Net revenue of the company rose substantially by 32.93 per cent at Rs 175.71 crore in January-March quarter of this fiscal as against Rs 132.18 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 54.27 per cent to Rs 150.51 cro...
Bajaj Healthcare Q4 net profit down 17.90% at Rs 17.47 cr
Bajaj Healthcare Q4 net profit down 17.90% at Rs 17.47 cr
Source: Dion Global Solutions Ltd
18/05/2022 2:09:53 PM
Bajaj Healthcare surges on launching Magnesium L-Threonate in Nutraceutical segment Bajaj Healthcare is currently trading at Rs. 390.25, up by 16.75 points or 4.48% from its previous closing of Rs. 373.50 on the BSE. The scrip opened at Rs. 375.95 and has touched a high and low of Rs. 399.00 and Rs. 375.85 respectively. So far 30886 shares were traded on the counter. The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 511.90 on 09-Jul-2021 and a 52 week low of Rs. 213.48 on 19-Apr-2021. Last one week high and low of the scrip stood ...
Bajaj Healthcare surges on launching Magnesium L-Threonate in Nutraceutical segment
Bajaj Healthcare surges on launching Magnesium L-Threonate in Nutraceutical segment
Source: Accord Fintech
23/02/2022 2:33:33 PM
Bajaj Healthcare launches Black Fungus API By Mr. Yash Gupta, Angel Broking Ltd Below are Quote on Bajaj Healthcare launches Black Fungus API by Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd    Bajaj Healthcare Limited, a leading manufacturer of APIs, Intermediates and Formulations, has announced the launch of Posaconazole API used in treating Mucormycosis (Black Fungus) infection in Covid-19 patients. Bajaj Healthcare has received approval from FDA Gandhi Nagar, Gujarat India, to manufacture and market “Posa...
Bajaj Healthcare launches Black Fungus API By Mr. Yash Gupta, Angel Broking Ltd
Bajaj Healthcare launches Black Fungus API By Mr. Yash Gupta, Angel Broking Ltd
Source: Angel Broking Ltd
28/05/2021 1:45:54 PM
Bajaj Healthcare zooms on launching anti-parasitic drug ‘Ivermectin’ Bajaj Healthcare is currently trading at Rs. 621.05, up by 33.65 points or 5.73% from its previous closing of Rs. 587.40 on the BSE. The scrip opened at Rs. 586.90 and has touched a high and low of Rs. 625.00 and Rs. 586.90 respectively. So far 296088 shares were traded on the counter. The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 625.00 on 06-May-2021 and a 52 week low of Rs. 238.05 on 11-May-2020. Last one week high and low of the scrip stoo...
Bajaj Healthcare zooms on launching anti-parasitic drug ‘Ivermectin’
Bajaj Healthcare zooms on launching anti-parasitic drug ‘Ivermectin’
Source: Accord Fintech
6/05/2021 1:47:53 PM
Bajaj Healthcare surges on launching antiviral drug `Favijaj` Bajaj Healthcare is currently trading at Rs. 597.50, up by 14.45 points or 2.48% from its previous closing of Rs. 583.05 on the BSE. The scrip opened at Rs. 614.40 and has touched a high and low of Rs. 619.00 and Rs. 552.65 respectively. So far 149195 shares were traded on the counter. The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 619.00 on 05-May-2021 and a 52 week low of Rs. 238.05 on 11-May-2020. Last one week high and low of the scrip stoo...
Bajaj Healthcare surges on launching antiviral drug `Favijaj`
Bajaj Healthcare surges on launching antiviral drug `Favijaj`
Source: Accord Fintech
5/05/2021 12:45:39 PM
Bajaj Healthcare surges on getting permission from MPCB to resume operations at Tarapur unit Bajaj Healthcare is currently trading at Rs. 495.00, up by 6.65 points or 1.36% from its previous closing of Rs. 488.35 on the BSE. The scrip opened at Rs. 494.90 and has touched a high and low of Rs. 502.40 and Rs. 492.20 respectively. So far 16362 shares were traded on the counter. The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 600.00 on 04-Feb-2021 and a 52 week low of Rs. 185.00 on 25-Mar-2020. Last one week high and low of the scrip stood ...
Bajaj Healthcare surges on getting permission from MPCB to resume operations at Tarapur unit
Bajaj Healthcare surges on getting permission from MPCB to resume operations at Tarapur unit
Source: Accord Fintech
3/03/2021 2:37:42 PM